Physician profile
Salvatore Docimo
NPI 1558691154
$537,015.06
in general payments reported to CMS, 2019-2025
23 companies · $160K in 2025
The $160K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $28K · 2021: $71K · 2022: $30K · 2023: $91K · 2024: $140K · 2025: $160K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $170K · Consulting Fee: $76K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $72K · Travel and Lodging: $51K · Food and Beverage: $19K · Education: $2,805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $169,597.00 |
| Consulting Fee | $75,988.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $72,025.00 |
| Travel and Lodging | $51,408.43 |
| Food and Beverage | $18,874.62 |
| Education | $2,805.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $282,429.42 | 2020-2025 | Phasix Mesh, Arista Ah Flexitip, Channel Drain |
| Boston Scientific Corporation | $136,857.30 | 2019-2025 | Spyglass Discover, Spyglass, Spyglass |
| Medtronic, INC. | $66,485.33 | 2021-2025 | Progrip, Absorbatack, Signia |
| Intuitive Surgical, INC. | $26,604.85 | 2020-2025 | Da Vinci Surgical System |
| Covidien Lp | $13,603.61 | 2019-2020 | |
| Becton, Dickinson and Company | $3,125.45 | 2024-2025 | Phasix Mesh |
| Medical Device Business Services, INC. | $2,556.71 | 2025 | Echelon; Endopath |
| Bard Peripheral Vascular, INC. | $1,725.00 | 2024 | |
| Integra Lifesciences Corporation | $867.95 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| W. L. Gore & Associates, INC. | $733.19 | 2019-2023 | Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Ethicon US, LLC | $708.46 | 2022-2025 | Echelon Endopath, Echelon Flex, Evicel Fibrin Sealant (Human) |
| Acera Surgical, INC. | $300.30 | 2024 | Restrata Wound Matrix |
| Ethicon INC. | $247.95 | 2025 | Monarch Platform |
| Activ Surgical, INC. | $150.00 | 2021 | |
| Baxter Healthcare | $143.26 | 2023-2025 | Tisseel |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $140.00 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $126.59 | 2022 | |
| Conmed Corporation | $125.00 | 2023 | Airseal |
| Acell, INC. | $33.02 | 2020 | |
| Currax Pharmaceuticals LLC | $16.82 | 2021 | |
| Teleflex LLC | $13.97 | 2023 | Titan Sgs Standard Gastric Stapler |
| Innocoll Pharmaceuticals Limited | $12.50 | 2021 | |
| Erbe USA INC | $8.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salvatore Docimo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.